Intracellular genomic transplant and methods of therapy

US11266692B2 · kind B2 · utility

Assignees

• Regents of the University of Minnesota · US
• INTIMA BIOSCIENCE, INC. · US
• The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

• Branden Moriarity · Shoreview, US
• Beau Webber · Coon Rapids, US
• Modassir Choudhry · New York, US
• Steven A. Rosenberg · Potomac, US
• Douglas C. Palmer · North Bethesda, US
• Nicholas P. Restifo · Chevy Chase Section Five, US

Key dates

• Filing date: Jun 12, 2020
• Grant date: Mar 8, 2022
• Expiry date: Jun 12, 2040

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2510/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.